{"schema_version":"secwatch.filing_event.v1","accession":"0001698530-23-000010","form_type":"8-K","ticker":"XCUR","cik":"0001698530","company_name":"EXICURE, INC.","filed_at":"2023-02-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:46.184872+00:00","generated_at":"2026-06-19T18:06:01.931203+00:00","sec_items":["5.02","7.01","8.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Exicure director resigns; Nasdaq extends equity compliance deadline, private placement closing by Feb 21","bullets":["Director Jeffrey Cleland resigned from board and all committees effective Feb 10, 2023.","Company non-compliant with Nasdaq independent director and audit committee requirements; cure period ongoing.","Nasdaq granted extension to file 10-K by March 31 to evidence compliance with $2.5M equity rule; risk of delisting.","Private placement of 3.4M shares at $1.60/share with CBI USA expected to close by Feb 21."],"urls":{"canonical":"https://secwatch.observer/filing/0001698530-23-000010","json":"https://secwatch.observer/filing/0001698530-23-000010.json","markdown":"https://secwatch.observer/filing/0001698530-23-000010.md","text":"https://secwatch.observer/filing/0001698530-23-000010.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1698530/000169853023000010/0001698530-23-000010-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1698530/000169853023000010/xcur-20230207.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-19T18:06:01.931203+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"4084ca0954","claim":"Jeffrey L. Cleland resigned as Director at EXICURE, INC..","evidence_excerpt":"Effective February 10, 2023, Dr. Cleland resigned from the Board, the Audit Committee, Compensation Committee and Nominating and Corporate Governance Committee of the Board.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1698530/000169853023000010/0001698530-23-000010-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}